Wyeth Quietly Turns Itself Into A Biotech Power
Nov. 26, 2007 (Investor's Business Daily delivered by Newstex) --
Pop quiz: Name the top three biotech companies by sales.
A no-brainer, right? Amgen (NASDAQ:AMGN) AMGN leads with 2006 revenue of $14.3 billion. Genentech (NYSE:DNA) DNA follows with $9.3 billion.
And next up is ... Wyeth (NYSE:WYE PR) (NYSE:WYE) WYE?